Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
2.
High Alt Med Biol ; 16(2): 154-61, 2015 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-25950723

RESUMEN

Lipman, Grant S., Nicholas C. Kanaan, Caleb Phillips, Dave Pomeranz, Patrick Cain, Kristin Fontes, Becky Higbee, Carolyn Meyer, Michael Shaheen, Sean Wentworth, and Diane Walsh. Study Looking at End Expiratory Pressure for Altitude Illness Decrease (SLEEP-AID). High Alt Med Biol 16:154-161, 2015.--Acute mountain sickness (AMS) affects 25%-70% of the tens of millions of high altitude travelers annually, with hypoxia and nocturnal desaturations as major contributing factors. This is the first double blind randomized placebo controlled trial to assess expiratory positive airway pressure (EPAP) for AMS prevention and nocturnal hypoxic events. Healthy adult participants trekking in the Khumbu region of the Himalayas were randomized to a single-use EPAP nasal strip, or a visually identical sham device (placebo) prior to first night sleeping between 4371-4530 m (14,340-14,800 ft). The primary outcome was AMS incidence, measured by Lake Louise Questionnaire (LLQ), with secondary outcomes of AMS severity (by LLQ) and physiologic sleep indices measured by continuous sleep monitor. Intent-to-treat analysis included 219 participants with comparable demographic characteristics, of which 115 received EPAP and 104 placebo. There was no decrease in AMS with EPAP intervention (14% EPAP vs. 17% placebo; p=0.65; risk difference (-)3.15%, 95% CI (-)12.85%-6.56%). While overall AMS severity was not different between groups, EPAP reported decreased incidence of headache (64% vs. 76%; p<0.05, OR 0.51, 95% CI 0.27-0.95) and dizziness (81% vs. 98%; p<0.03, OR 0.29, 95% CI 0.09-0.78). During sleep, EPAP resulted in significant improvements in average peripheral oxygenation (Spo(2)) (80% versus 78%; p<0.01, mean difference=2, 95% CI 0.58-3.63) and a reduced percentage of time below 80% Spo(2) (31% vs. 46%; p<0.03, median difference=16, 95% CI 2.22-28.18). This lightweight and inexpensive EPAP device did not prevent acute mountain sickness, but did reduce the subgroup incidence of headache and dizziness while improving average nighttime peripheral oxygenation.


Asunto(s)
Mal de Altura/prevención & control , Altitud , Respiración con Presión Positiva , Sueño/fisiología , Enfermedad Aguda , Adulto , Mal de Altura/epidemiología , Método Doble Ciego , Femenino , Humanos , Incidencia , Masculino , Nepal , Oxígeno/metabolismo , Polisomnografía , Intercambio Gaseoso Pulmonar/fisiología , Índice de Severidad de la Enfermedad , Encuestas y Cuestionarios , Factores de Tiempo
3.
J Urol ; 177(5): 1632-5, 2007 May.
Artículo en Inglés | MEDLINE | ID: mdl-17437775

RESUMEN

PURPOSE: This review is of the events that led up to the discovery of the cavernous nerves and the development of nerve sparing radical retropubic prostatectomy. MATERIALS AND METHODS: The correspondence between Pieter J. Donker and Patrick C. Walsh, along with the publication folders describing the anatomy of the dorsal vein complex, pelvic plexus and cavernous nerves, and pelvic fascia, are reviewed. RESULTS: Serendipity had a major role in the fateful meeting of Pieter J. Donker and Patrick C. Walsh on February 13, 1981 when they dissected out the cavernous nerves in a stillborn male infant. During the next year intraoperative observations identified the capsular arteries and veins of the prostate as the likely microscopic landmark that could be used in the adult male pelvis to identify the microscopic cavernous nerves. Twenty-five years ago, on April 26, 1982, the first purposeful nerve sparing radical prostatectomy was performed. One year following surgery patient sexual function was normal, and 25 years later he has retained his quality of life and an undetectable prostate specific antigen. CONCLUSIONS: The events that led up to the first nerve sparing radical prostatectomy illustrate the influence of serendipity on discovery.


Asunto(s)
Anatomía/historia , Plexo Hipogástrico/anatomía & histología , Pene/inervación , Prostatectomía/historia , Historia del Siglo XX , Humanos , Masculino , Prostatectomía/métodos
5.
J Biol Chem ; 270(9): 4509-17, 1995 Mar 03.
Artículo en Inglés | MEDLINE | ID: mdl-7876219

RESUMEN

The MF3 protein specifically recognizes telomeric and non-telomeric DNA probes that can form G.G base-paired structures (Gualberto, A., Patrick, R. M., and Walsh, K. (1992) Genes & Dev. 6, 815-824). Here we further characterize the nucleic acid recognition properties of MF3 and present a mathematical analysis that evaluates the potential extent of telomere site occupancy by this factor. The substitution of dI at dG positions in telomeric DNA probes revealed that a single dG at any position within the internal repeat was sufficient for high affinity binding to MF3. The RNA analogs of high affinity DNA sites were not bound specifically by MF3, but the substitution of dU for dT in a DNA probe had little or no effect on binding. These data demonstrate that ribose ring structure is a critical feature of nucleoprotein complex formation, and this ribose specificity may enable MF3 to occupy sites of unusual DNA structure while minimizing interactions with cellular RNAs. Collectively, the nucleic acid binding properties of MF3 suggest that it may occupy a significant fraction of sites at telomere ends or other G-rich regions of altered DNA structure in vivo.


Asunto(s)
Proteínas de Unión al ADN/metabolismo , Aminas/metabolismo , Animales , Secuencia de Bases , Sitios de Unión , Embrión de Pollo , ADN/metabolismo , Sondas de ADN , Proteínas de Unión al ADN/química , Modelos Teóricos , Datos de Secuencia Molecular , Conformación Proteica , Ribosa/química , Pavos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...